Codiak BioSciences
Financial ratios & Valuation

Historical Multiples (2018 – 2021)

2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.56-2.00-2.30-5.83-0.03-2.00
Price/Sales ratio
N/A410.2270.1710.580.0770.17
Price/Book Value ratio
1.727.2514.044.530.0314.04
Price/Cash Flow ratio
-5.19-93.46-3.22-3.27-0.03-93.46
Price/Free Cash Flow ratio
-4.08-13.06-2.42-3.13-0.03-13.06
Price/Earnings Growth ratio
N/A-0.02-0.010.06-0.00-0.02
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A100%100%100%65.34%100%
Operating Profit Margin
N/A-20657.73%-3118.97%-303.24%-264.98%-20657.73%
Pretax Profit Margin
N/A-20092.78%-3144.59%-162.01%-195.00%-20092.78%
Net Profit Margin
N/A-20425.77%-3050.80%-181.52%-195.00%-20425.77%
Effective Tax Rate
-4.26%-1.65%2.98%-12.04%N/A-1.65%
Return on Assets
-45.60%-68.34%-58.76%-24.25%-29.18%-68.34%
Return On Equity
-48.39%-361.04%-610.49%-77.81%-84.72%-361.04%
Return on Capital Employed
-50.06%-83.31%-68.00%-48.12%-44.44%-83.31%
Liquidity Ratios
Current Ratio
N/AN/A5.31N/A4.235.31
Quick Ratio
18.604.655.313.313.585.31
Cash ratio
3.690.525.032.833.580.52
Days of Sales Outstanding
N/A5.55KN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.080.410.360.710.08
Debt Equity Ratio
N/A0.434.321.172.450.43
Long-term Debt to Capitalization
N/A0.300.800.520.590.30
Total Debt to Capitalization
N/A0.300.810.540.610.30
Interest Coverage Ratio
N/AN/A-47.70N/A25.6725.67
Cash Flow to Debt Ratio
N/A-0.17-1.00-1.17-0.74-0.74
Company Equity Multiplier
1.065.2810.383.203.4510.38
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-4.38-21.73-3.23-2.26-4.38
Free Cash Flow / Operating Cash Flow Ratio
1.277.151.331.041.001.33
Cash Flow Coverage Ratio
N/A-0.17-1.00-1.17-0.74-0.74
Short Term Coverage Ratio
N/AN/A-42.75-27.86-15.13-15.13
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A